Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosisRoss L. Levine, D. Gary Gilliland, Martha Wadleigh et al.|Cancer Cell|2005Cited by 3k
Immunogenomic profiling determines responses to combined PARP and PD-1 inhibition in ovarian cancerAnniina Färkkilä, Panagiotis A. Konstantinopoulos, D. Gulhan et al.|Nature Communications|2020Cited by 342
Expanded roles of the Fanconi anemia pathway in preserving genomic stabilityYounghoon Kee, Alan D. D’Andrea|Genes & Development|2010Cited by 308
UBE2T Is the E2 in the Fanconi Anemia Pathway and Undergoes Negative AutoregulationYuichi Machida, Anindya Dutta, Yuka Machida et al.|Molecular Cell|2006Cited by 292
Synthetic lethality between <i>CCNE1</i> amplification and loss of <i>BRCA1</i>Dariush Etemadmoghadam, David D.L. Bowtell, Barbara A. Weir et al.|Proceedings of the National Academy of Sciences|2013Cited by 227